Findings from University of Bergen Yields New Findings on Disease Biomarkers [Increased Expression of Cxcl10 and Ccl3 Salivary Gland Chemokines In Primary Sjogren's Syndrome Detected and Systematically Quantified Using Rnascope(R) in Situ...].

A recent study conducted at the University of Bergen in Norway focused on identifying disease biomarkers in patients with Primary Sjogren's Syndrome, a chronic inflammatory condition affecting exocrine glands. The research found increased expression of CXCL10 and CCL3 chemokines in the saliva and minor salivary glands of patients with the syndrome, suggesting CXCL10 as a potential disease biomarker due to its upregulated expression and tissue localization. Further studies are recommended to validate the findings and explore the functional implications of these biomarkers. [Extracted from the article]

Copyright of Genomics & Genetics Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)